BioNTech SE (BVMF:B1NT34)
28.83
-1.14 (-3.80%)
At close: Oct 8, 2026
BioNTech SE Revenue
BioNTech SE had revenue of 145.80M EUR in the quarter ending June 30, 2026, a decrease of -56.99%. This brings the company's revenue in the last twelve months to 2.78B, down -3.41% year-over-year. In the year 2025, BioNTech SE had annual revenue of 3.05B with 5.63% growth.
Revenue (ttm)
2.78B EUR
Revenue Growth
-3.41%
P/S Ratio
7.38
Revenue / Employee
356.13K EUR
Employees
7,807
Market Cap
115.83B BRL
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.05B | 162.80M | 5.63% |
| Dec 31, 2024 | 2.89B | -1.03B | -26.31% |
| Dec 31, 2023 | 3.92B | -13.39B | -77.33% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Dec 31, 2019 | 108.60M | -18.98M | -14.87% |
| Dec 31, 2018 | 127.58M | 65.98M | 107.11% |
| Dec 31, 2017 | 61.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 57.79B |
| Raia Drogasil | 46.53B |
| Empreendimentos Pague Menos | 15.64B |
| Bradsaúde | 10.68B |
| Diagnósticos da América | 9.32B |
| Hypera | 8.82B |
| Fleury | 8.79B |
| Dimed S.A. Distribuidora de Medicamentos | 5.90B |
BioNTech SE News
- 3 hours ago - BioNTech price target lowered to $114 from $122 at BofA - TheFly
- 1 day ago - BioNTech initiated with a Hold at Argus - TheFly
- 2 days ago - BioNTech price target lowered to $114 from $115 at Morgan Stanley - TheFly
- 11 days ago - BioNTech to shutter sites in Germany, Singapore as no buyers emerge - Reuters
- 21 days ago - Health Canada authorizes Pfizer, BioNTech’s Omicron XFG-adapted Covid-19 vaccine - TheFly
- 23 days ago - BioNTech price target raised to $140 from $132 at Berenberg - TheFly
- 25 days ago - BioNTech, OncoC4 announce first median overall survival data from PRESERVE-003 - TheFly
- 25 days ago - BioNTech says lung cancer drug candidate prolonged lives in trial - Reuters